Screening and Prostate-Cancer Mortality in a Randomized European Study

A Multiple Testing Procedure for Clinical Trials

1979 • 3,139 citations

Mortality Results from a Randomized Prostate-Cancer Screening Trial

2009 • 2,828 citations

Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

1987 • 2,447 citations

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1991 • 2,353 citations

Nonparametric Inference for a Family of Counting Processes

1978 • 1,441 citations

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer

2003 • 1,066 citations

Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An Update

2008 • 966 citations

A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer

1995 • 735 citations

International encyclopedia of public health

2009 • 470 citations

Making the most out of six systematic sextant biopsies

1995 • 440 citations

Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

2002 • 401 citations

Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer

1998 • 341 citations

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

2006 • 308 citations

Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer

1994 • 276 citations

Health-Related Quality-of-Life Effects of Radical Prostatectomy and Primary Radiotherapy for Screen-Detected or Clinically Diagnosed Localized Prostate Cancer

2001 • 225 citations

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer

1995 • 206 citations

Short-Term Effects of Population-Based Screening for Prostate Cancer on Health-Related Quality of Life

1998 • 177 citations

Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trial

2001 • 172 citations

PSA doubling time predicts the outcome after active surveillance in screening‐detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section

2006 • 156 citations

The story of the European Randomized Study of Screening for Prostate Cancer

2003 • 150 citations

Prostate-specific antigen-based early detection of prostate cancer—validation of screening without rectal examination

2001 • 124 citations

Individualized Screening Interval for Prostate Cancer Based on Prostate-Specific Antigen Level

2005 • 88 citations

Determining the cause of death in randomized screening trial(s) for prostate cancer

2003 • 86 citations

Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study

2002 • 83 citations

Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam)

2005 • 76 citations

Interval Cancers in Prostate Cancer Screening: Comparing 2- and 4-Year Screening Intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam

2007 • 72 citations

Nomogram use for the prediction of indolent prostate cancer

2007 • 72 citations

Report of the consensus workshop on screening and global strategy for prostate cancer

1995 • 68 citations

Prostate cancer diagnosis: The impact on patients’ mental health

2005 • 50 citations

A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55–75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam)

2005 • 45 citations

Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment

2001 • 45 citations

Measuring disease specific quality of life in localized prostate cancer: the Dutch experience.

2003 • 39 citations

Hybritech Total and Free Prostate-specific Antigen Assays Developed for the Beckman Coulter Access Automated Chemiluminescent Immunoassay System: A Multicenter Evaluation of Analytical Performance

2001 • 28 citations

Side‐effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?

2007 • 25 citations

Monitoring the ERSPC trial

2003 • 17 citations

Including the quality‐of‐life effects in the evaluation of prostate cancer screening: expert opinions revisited?

2003 • 16 citations

The Data Monitoring Committee – bridging the gap between urology and public health epidemiology

2003 • 7 citations

Deleted Work

1955 • 0 citations